Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors

NCT05060432 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Lung Cancer
Head and Neck Cancer
Melanoma

Interventions

DRUG: EOS-448
DRUG: pembrolizumab
DRUG: inupadenant
DRUG: Dostarlimab
DRUG: SOC chemotherapies

Sponsor

iTeos Belgium SA

Collaborators

[object Object]
[object Object]